Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients.

MLA

Barrera-Baena, Pedro, et al. “Serum Phosphate Is Associated with Increased Risk of Bone Fragility Fractures in Haemodialysis Patients.” Nephrology Dialysis Transplantation, vol. 39, no. 4, Apr. 2024, pp. 618–26. EBSCOhost, https://doi.org/10.1093/ndt/gfad190.

APA

Barrera-Baena, P., Rodríguez-García, M., Rodríguez-Rubio, E., González-Llorente, L., Ortiz, A., Zoccali, C., Locatelli, F., Floege, J., Cohen-Solal, M., Ferreira, M. A., Ketteler, M., London, G. M., Gorriz-Teruel, J. L., Sánchez-Álvarez, E., Hevia-Suárez, M. Á., Fernández-Gómez, J. M., Martín-Carro, B., Gómez-Alonso, C., Alonso-Montes, C., & Cannata-Andía, J. B. (2024). Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients. Nephrology Dialysis Transplantation, 39(4), 618–626. https://doi.org/10.1093/ndt/gfad190

Chicago

Barrera-Baena, Pedro, Minerva Rodríguez-García, Enrique Rodríguez-Rubio, Lucía González-Llorente, Alberto Ortiz, Carmine Zoccali, Francesco Locatelli, et al. 2024. “Serum Phosphate Is Associated with Increased Risk of Bone Fragility Fractures in Haemodialysis Patients.” Nephrology Dialysis Transplantation 39 (4): 618–26. doi:10.1093/ndt/gfad190.